Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.59 |
| ▸ | DRD2 | P14416 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.56 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.56 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.56 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.56 |
| ▸ | DRD1 | P21728 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 1/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | HRH1 | P35367 | 1/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9181334 | 1.00 | HRH4 (0.59) | HRH4DRD2LMNACHRM2HTR1A | |
| SCHEMBL11559143 | 0.90 | DRD2 (0.59) | HRH4DRD2LMNACHRM2HTR1A | |
| SCHEMBL9178906 | 0.88 | HRH4 (0.53) | HRH4DRD2ADRA2AHTR2ADRD4 | |
| SCHEMBL9211771 | 0.85 | DRD2 (0.72) | HRH4DRD2LMNACHRM2HTR1A | |
| SCHEMBL144624 | 0.84 | DRD2 (0.74) | HRH4DRD2LMNACHRM2HTR1A | |
| SCHEMBL140462 | 0.78 | HRH4 (0.65) | HRH4DRD2LMNACHRM2HTR1A | |
| SCHEMBL29407324 | 0.78 | HRH4 (0.65) | HRH4DRD2LMNACHRM2HTR1A | |
| Fumaric Acid SCHEMBL9174545 | 0.78 | DRD4 (0.62) | HRH4DRD2LMNACHRM2HTR1A | |
| Fumaric Acid SCHEMBL9174551 | 0.78 | DRD4 (0.62) | HRH4DRD2LMNACHRM2HTR1A | |
| SCHEMBL8022151 | 0.76 | DRD2 (0.80) | HRH4DRD2LMNACHRM2HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119140287-A | Equal floatable separation process for lepidolite containing mud | 江西九岭锂业股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| US-20240067689-A1 | INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF | MEDICENNA THERAPEUTICS INC (CA) | 2024-02-29 | — | — | US | claimed |
| CN-114704874-B | Precise control method for heating parameters of heating power station based on flexible heating system | 内蒙古思铂睿特节能科技有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-115873668-A | Formula of integrated plant compounded plant type laundry detergent for daily chemical products | 贵州华波日化有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-114704874-A | Accurate control method for heating parameters of heating station based on flexible heating system | 内蒙古思铂睿特节能科技有限公司 | 2022-07-05 | — | — | CN | claimed |
| US-20260144857-A1 | SHIGELLA MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION AND FUSION PROTEINS THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260116940-A1 | MASKED CYTOKINE POLYPEPTIDES | XILIO DEV INC (US) | 2026-04-30 | — | — | US | disclosed |
| CN-119140287-B | Equal floatable separation process for lepidolite containing mud | 江西九岭锂业股份有限公司 | 2025-09-19 | — | — | CN | disclosed |
| US-20250282851-A1 | Monoclonal Antibody A38 Against Rift Valley Fever Virus and Use | ACADEMY OF MILITARY MEDICAL SCIENCE, PLA (CN) | 2025-09-11 | — | — | US | disclosed |
| US-20250207850-A1 | BREWING AND COOLING A BEVERAGE | COLDSNAP, CORP. | 2025-06-26 | — | — | US | disclosed |
| EP-3823592-B1 | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET AGENT | UNIV HONG KONG SCIENCE & TECH (CN) | 2025-06-25 | — | — | EP | disclosed |
| WO-2025118037-A1 | BINDING PROTEINS AND METHODS AND USES THEREOF | MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED (AU) | 2025-06-12 | — | — | WO | disclosed |
| WO-2022140354-A1 | ARTIFICIAL ANTIGEN-SPECIFIC IMMUNOREGULATORY T (AIRT) CELLS | Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) | 2022-06-30 | — | — | WO | disclosed |
| CN-114676497-A | Underwater vehicle reliability verification method based on Bayes method | 中国人民解放军海军工程大学 | 2022-06-28 | — | — | CN | disclosed |
| WO-2022132696-A1 | UREA OREXIN RECEPTOR AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2022-06-23 | — | — | WO | disclosed |
| EP-3972997-A1 | NOVEL ANTI-CD25 ANTIBODIES | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2022-03-30 | — | — | EP | disclosed |
| CN-106732749-B | One-step synthesis preparation method of hydrocracking catalyst | 中国海洋石油集团有限公司 | 2022-03-29 | — | — | CN | disclosed |
| EP-3969447-A1 | CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF | Nurix Therapeutics, Inc. (US) | 2022-03-23 | — | — | EP | disclosed |
| CN-114107122-A | Method for relieving gout by using probiotic fermented food slurry | 兰州大学 | 2022-03-01 | — | — | CN | disclosed |
| WO-2022035863-A1 | METHOD FOR TREATING CARDIAC CONDITIONS WITH PLACENTA-DERIVED COMPOSITIONS | MUSCULOSKELETAL TRANSPLANT FOUNDATION (US) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144857-A1 | SHIGELLA MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION AND FUSION PROTEINS THEREOF | HLA-DRB1, SPOP, STXBP1 | HRH4 4616/4885DRD2 3382/4885LMNA 2338/4885 |
| US-20260116940-A1 | MASKED CYTOKINE POLYPEPTIDES | TNFRSF9, IL36G, TNFSF11 | HRH4 1174/4885DRD2 4320/4885LMNA 1674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.